|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.400 GBX | 0.00% |
|
-6.85% | -33.66% |
| Jul. 03 | Medpal AI raises GBP5 million amid focus on oral Wegovy launch | AN |
| Jul. 03 | WINNERS & LOSERS: RC365 jumps on partnership; Craneware slides | AN |
| Fiscal Period: August | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
Selling General & Admin Expenses, Total | 35.62K | 13.59K | 13.36K | 2.16M |
Other Operating Expenses, Total | 35.62K | 13.59K | 13.36K | 2.16M |
Operating Income | -35.62K | -13.59K | -13.36K | -2.16M |
Other Non Operating Income (Expenses) | -250 | -228 | -228 | -1.84M |
EBT, Excl. Unusual Items | -35.87K | -13.82K | -13.59K | -4M |
Merger & Related Restructuring Charges | -19.65K | - | - | - |
EBT, Incl. Unusual Items | -55.52K | -13.82K | -13.59K | -4M |
Earnings From Continuing Operations | -55.52K | -13.82K | -13.59K | -4M |
Net Income to Company | -55.52K | -13.82K | -13.59K | -4M |
Net Income - (IS) | -55.52K | -13.82K | -13.59K | -4M |
Net Income to Common Incl Extra Items | -55.52K | -13.82K | -13.59K | -4M |
Net Income to Common Excl. Extra Items | -55.52K | -13.82K | -13.59K | -4M |
Per Share Items | ||||
Net EPS - Basic | -0 | -0 | -0 | -0.02 |
Basic EPS - Continuing Operations | -0 | -0 | -0 | -0.02 |
Basic Weighted Average Shares Outstanding | 40.14M | 45.5M | 45.93M | 175M |
Net EPS - Diluted | -0 | -0 | -0 | -0.02 |
Diluted EPS - Continuing Operations | -0 | -0 | -0 | -0.02 |
Diluted Weighted Average Shares Outstanding | 40.14M | 45.5M | 45.93M | 175M |
Normalized Basic EPS | -0 | -0 | -0 | -0.01 |
Normalized Diluted EPS | -0 | -0 | -0 | -0.01 |
Supplemental Items | ||||
EBITA | -35.62K | -13.59K | -13.36K | -2.16M |
EBIT | -35.62K | -13.59K | -13.36K | -2.16M |
Normalized Net Income | -22.42K | -8.64K | -8.49K | -2.5M |
Supplemental Operating Expense Items | ||||
Advertising Expense | - | - | - | 446K |
Selling and Marketing Expenses | - | - | - | 446K |
General and Administrative Expenses | 33.09K | 13.45K | 13.36K | 1.37M |
Stock-Based Comp., G&A Exp. (Total) | - | - | - | 1.11M |
Stock-Based Comp., Other (Total) | - | - | - | 1.27M |
Total Stock-Based Compensation | - | - | - | 2.39M |
- Stock Market
- Stocks
- MPAL Stock
- Financials MedPal AI PLC
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















